List of Oncology Medication For

Chronic Disease

Specialty medications are used to treat patients with complex and/or rare diseases; have special dosage, storage, handling, and administration requirements; and require high touch patient care and monitoring services (eg, transplant, oncology, MS, hepatitis).

Dulaglutide Injection

Diabetes

dulaglutide injection
for subcutaneous use Initial U.S. Approval: 2014

Facts about dulaglutide injection

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): dulaglutide
Dosage Forms And Strengths: Injection: 0.75 mg/0.5 mL solution in a single-dose pen
Injection: 1.5 mg/0.5 mL solution in a single-dose pen
Injection: 0.75 mg/0.5 mL solution in a single-dose prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose prefilled syringe
Company: Eli Lilly
Diseases: Type 2 diabetes, cardiovascular risk reduction
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “dulaglutide injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

ELAHERE (mirvetuximab soravtansine-gynx) injection

Ovarian, Chronic Disease

Brand Name: ELAHERE Generic Name: mirvetuximab soravtansine-gynx. It is used to treat folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Brand Name:	ELAHERE
Generic Name:	mirvetuximab soravtansine-gynx
Strength:	• Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial.
Manufacturer:	ImmunoGen
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “ELAHERE (mirvetuximab soravtansine-gynx) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Empagliflozin and Linagliptin Tablets

Diabetes

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

Facts about empagliflozin and linagliptin tablets

Approval Date: 2015
Proprietary Name: GLYXAMBI (empagliflozin and linagliptin) tablets
Active Ingredient(s): empagliflozin and linagliptin
FDA-approved use:
Dosage Form: Tablets: • 10 mg empagliflozin/5 mg linagliptin • 25 mg empagliflozin/5 mg linagliptin
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Empagliflozin and Linagliptin Tablets” based on the information you provide.

Ertugliflozin Tablets

Diabetes

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

STEGLATRO is a sodium glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about ertugliflozin tablets

Approval Date: 2017
Proprietary Name: STEGLATRO (ertugliflozin) tablets
Active Ingredient(s): ertugliflozin tablets
Dosage Form: Tablets: 5 mg and 15 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Merck Sharp & Dohme Corp.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ertugliflozin Tablets” based on the information you provide.

Everolimus Tablets

Breast Cancer, Gastrointestinal, Kidney, Lung Cancer

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

Afinitor (everolimus) is a medication used to treat patients with advanced HR+, HER2- breast cancer; progressive neuroendocrine tumors of pancreatic origin (PNET); progressive neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin; advanced renal cell carcinoma; and subependymal giant cell astrocytoma (SEGA) and renal angiomyolipomas associated with tuberous sclerosis.

Facts about everolimus tablets

Disease Indications-Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer
Manufacturer-Novartis
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA).
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “everolimus tablets” based on the information you provide.

Exenatide Injection

Diabetes

exenatide Injection
Initial U.S. Approval: 2005

BYETTA is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Facts about exenatide Injection

Approval Date: 2005
Proprietary Name: BYETTA (exenatide) Injection
Active Ingredient(s): exenatide
FDA-approved use: 2 diabetes mellitus.
Dosage Form: BYETTA is supplied as 250 mcg/mL exenatide in: • 5 mcg per dose, 60 doses, 1.2 mL prefilled pen • 10 mcg per dose, 60 doses, 2.4 mL prefilled pen.
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: Amylin Pharmaceuticals, Inc.
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Exenatide Injection” based on the information you provide.

Fampridine Tablets

Fampridine 10 mg Modified Release (MR) tablet

Generic Name – Fampyra
Medicine Type – Tablets / Oral
Manufacturer Name – Biogen Idec Ltd
Approval Year – 2011
Approved by – The European Commission

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import fampridine tablets” based on the information you provide.

FASENRA (benralizumab) injection

Cardiology

FASENRA (benralizumab) injection

FASENRA is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Brand Name:	Fasenra
Generic Name:	Benralizumab
Strength:	• Injection: 30 mg/mL Solution in a Single-dose Prefilled Syringe
Manufacturer:	AstraZeneca
Approved By:	EMA, USFDA

Source Details: Patient Information

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import FASENRA (benralizumab) injection” based on the information you provide.

FOTIVDA (tivozanib) capsules

Kidney

Brand Name: FOTIVDA Generic Name: tivozanib. It is used to treat renal cell carcinoma (RCC).

FOTIVDA is a kinase inhibitor indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.

Brand Name:	FOTIVDA
Generic Name:	tivozanib
Strength:	• Capsules: 1.34 mg and 0.89 mg
Manufacturer:	AVEO Pharmaceuticals, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “FOTIVDA (tivozanib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Gemcitabine for injection

Ovarian, Bile Duct Cancer, Breast Cancer, Lung Cancer, Pancreatic

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Chronic Disease

dulaglutide injection for subcutaneous use Initial U.S. Approval: 2014

Facts about dulaglutide injection

Access the best support services globally

Brand Name: ELAHERE Generic Name: mirvetuximab soravtansine-gynx. It is used to treat folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

empagliflozin and linagliptin tablets for oral use Initial U.S. Approval: 2015

Access the best support services globally

ertugliflozin tablets for oral use Initial U.S. Approval: 2017

Facts about ertugliflozin tablets

Access the best support services globally

everolimus tablets for oral suspension Initial U.S. Approval: 2009

Facts about everolimus tablets

Access the best support services globally

exenatide Injection Initial U.S. Approval: 2005

Access the best support services globally

Fampridine 10 mg Modified Release (MR) tablet

Access the best support services globally

FASENRA (benralizumab) injection

Access the best support services globally

Brand Name: FOTIVDA Generic Name: tivozanib. It is used to treat renal cell carcinoma (RCC).

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

dulaglutide injection
for subcutaneous use Initial U.S. Approval: 2014

empagliflozin and linagliptin tablets
for oral use Initial U.S. Approval: 2015

ertugliflozin tablets
for oral use Initial U.S. Approval: 2017

everolimus tablets for oral suspension
Initial U.S. Approval: 2009

exenatide Injection
Initial U.S. Approval: 2005